Edition:
United Kingdom

Insider Trading: CytomX Therapeutics Inc (CTMX.OQ)

CTMX.OQ on NASDAQ Stock Exchange Global Select Market

9.98USD
24 Apr 2019
Change (% chg)

$-0.03 (-0.30%)
Prev Close
$10.01
Open
$10.06
Day's High
$10.21
Day's Low
$9.76
Volume
116,182
Avg. Vol
174,413
52-wk High
$27.19
52-wk Low
$9.30

All Insider Trades
Trading Date Name Title Type Shares Traded Price
8 Apr 2019

Gluck (Frederick W)

Director Gift 3,900 $0.00
8 Apr 2019

Gluck (Frederick W)

Director Gift 3,900 $0.00
4 Mar 2019

ROWLAND LLOYD A

General Counsel Buy 9,000 $10.33
12 Dec 2018

Ray (Debanjan)

Chief Financial Officer Sell 3,000 $15.00
12 Dec 2018

Ray (Debanjan)

Chief Financial Officer Buy 3,000 $1.45
30 Nov 2018

ROWLAND LLOYD A

General Counsel Buy 979 $11.73
30 Nov 2018

McCarthy (Sean A Ph.D.)

Chief Executive Officer Buy 468 $11.73
2 Nov 2018

McCarthy (Sean A Ph.D.)

Chief Executive Officer Buy 1,156 $1.57
2 Nov 2018

McCarthy (Sean A Ph.D.)

Chief Executive Officer Sell 1,156 $15.01
1 Nov 2018

Ray (Debanjan)

Chief Financial Officer Buy 3,000 $1.45
1 Nov 2018

McCarthy (Sean A Ph.D.)

Chief Executive Officer Sell 5,270 $15.00
1 Nov 2018

Ray (Debanjan)

Chief Financial Officer Sell 3,000 $15.00
1 Nov 2018

McCarthy (Sean A Ph.D.)

Chief Executive Officer Buy 5,370 $1.57
1 Nov 2018

McCarthy (Sean A Ph.D.)

Chief Executive Officer Sell 100 $15.01
1 Oct 2018

Ray (Debanjan)

Chief Financial Officer Sell 3,000 $18.46
1 Oct 2018

Ray (Debanjan)

Chief Financial Officer Buy 3,000 $1.45
4 Sep 2018

McCarthy (Sean A Ph.D.)

Chief Executive Officer Buy 13,052 $1.57
4 Sep 2018

McCarthy (Sean A Ph.D.)

Chief Executive Officer Sell 13,052 $21.86
4 Sep 2018

Ray (Debanjan)

Chief Financial Officer Buy 3,000 $1.45
4 Sep 2018

Ray (Debanjan)

Chief Financial Officer Sell 3,000 $22.39
1 Aug 2018

Ray (Debanjan)

Chief Financial Officer Sell 3,000 $26.05
1 Aug 2018

Ray (Debanjan)

Chief Financial Officer Buy 290 $1.45
1 Aug 2018

Ray (Debanjan)

Chief Financial Officer Buy 2,710 $1.26
5 Jul 2018

McCarthy (Sean A Ph.D.)

Chief Executive Officer Buy 4,497 $1.57
5 Jul 2018

McCarthy (Sean A Ph.D.)

Chief Executive Officer Sell 4,497 $25.06

Institutional Holders

% Shares Owned: 87.65%
# of Holders: 173
Total Shares Held: 39,672,064
3 Mo. Net Change: 631,219
# New Positions: 6
# Closed Positions: 5
# Increased Positions: 14
# Reduced Positions: 16
# Net Buyers: -2

Officers & Directors

Name Age Since Current Position

Sean McCarthy

51 2018 Chairman of the Board, President, Chief Executive Officer

Debanjan Ray

40 2018 Chief Financial Officer and Head of Corporate Development

Nick Galli

2019 Senior Vice President, Chief Business Officer

Leslie Robbins

2019 Senior Vice President - Intellectual Property

W. Michael Kavanaugh

61 2015 Chief Scientific Officer and Head - Research and Non-Clinical Development

Rachel Humphrey

56 2015 Chief Medical Officer

Matthew Young

48 2018 Lead Independent Director

Charles Fuchs

57 2017 Director

Marion McCourt

58 2017 Director

John Scarlett

67 2016 Director

Frederick Gluck

82 Independent Director

James Meyers

53 2018 Independent Director

Christopher Keenan

2018 Vice President, Investor Relations and Corporate Communications Vice President, Investor Relations and Corporate Communications